National Vision Holdings EBITDA 2015-2024 | EYE
National Vision Holdings Annual EBITDA (Millions of US $) |
|
---|---|
2023 | $58 |
2022 | $171 |
2021 | $281 |
2020 | $190 |
2019 | $162 |
2018 | $119 |
2017 | $133 |
2016 | $121 |
2015 | $93 |
2014 | $38 |
National Vision Holdings Quarterly EBITDA (Millions of US $) |
|
---|---|
2024-06-30 | $25 |
2024-03-31 | $50 |
2023-12-31 | $21 |
2023-09-30 | $-51 |
2023-06-30 | $32 |
2023-03-31 | $55 |
2022-12-31 | $22 |
2022-09-30 | $41 |
2022-06-30 | $44 |
2022-03-31 | $63 |
2021-12-31 | $38 |
2021-09-30 | $77 |
2021-06-30 | $80 |
2021-03-31 | $86 |
2020-12-31 | $84 |
2020-09-30 | $82 |
2020-06-30 | $-17 |
2020-03-31 | $42 |
2019-12-31 | $32 |
2019-09-30 | $34 |
2019-06-30 | $43 |
2019-03-31 | $53 |
2018-12-31 | $1 |
2018-09-30 | $18 |
2018-06-30 | $43 |
2018-03-31 | $57 |
2017-12-31 | $16 |
2017-09-30 | $33 |
2017-06-30 | $29 |
2017-03-31 | $55 |
2016-12-31 | |
2016-09-30 | $14 |
2015-12-31 | |
2014-12-31 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $0.867B | $2.126B |
National Vision Holdings, Inc. is one of the leading and rapidly growing optical retailers in the U.S. It provides budget-friendly eye exams, eyeglasses and contact lenses to low-income consumers and aims at making eye care and eyewear reasonable for all Americans. The company operates through a diverse portfolio of retail stores across brands and consumer websites. The company uses third-party carriers to transport all products from the distribution centers to the destination. It operates through 2 reportable segments. Owned & host segment includes the company's owned brands, namely, America's Best and Eyeglass World along with its Vista Optical locations in Fred Meyer stores. National Vision also provides affordable eye care products and services to American military service members within the owned & host segment. Legacy segment comprises National Vision's old strategic collaboration with Walmart to run to Vision Centers in certain Walmart stores. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $195.617B | 25.27 |
Stryker (SYK) | United States | $137.290B | 32.08 |
Boston Scientific (BSX) | United States | $122.743B | 37.38 |
Medtronic (MDT) | Ireland | $114.552B | 17.05 |
EssilorLuxottica (ESLOY) | France | $108.842B | 0.00 |
Haleon (HLN) | United Kingdom | $48.651B | 35.57 |
Lonza Group Ag (LZAGY) | Switzerland | $46.030B | 0.00 |
ResMed (RMD) | United States | $35.117B | 30.92 |
Koninklijke Philips (PHG) | Netherlands | $30.774B | 23.39 |
Terumo (TRUMY) | Japan | $28.517B | 40.27 |
Zimmer Biomet Holdings (ZBH) | United States | $22.039B | 13.87 |
Baxter (BAX) | United States | $19.851B | 13.46 |
Insulet (PODD) | United States | $16.269B | 68.45 |
Smith & Nephew SNATS (SNN) | United Kingdom | $13.605B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $9.247B | 30.63 |
Demant (WILYY) | Denmark | $8.667B | 0.00 |
BellRing Brands (BRBR) | United States | $7.898B | 33.39 |
Lantheus Holdings (LNTH) | United States | $7.454B | 17.89 |
ICU Medical (ICUI) | United States | $4.261B | 40.67 |
Haemonetics (HAE) | United States | $4.084B | 20.20 |
TG Therapeutics (TGTX) | United States | $3.689B | 39.07 |
Neogen (NEOG) | United States | $3.599B | 37.75 |
Prestige Consumer Healthcare (PBH) | United States | $3.534B | 17.61 |
GN Store Nord (GNNDY) | Denmark | $3.509B | 21.14 |
Perrigo (PRGO) | Ireland | $3.499B | 11.06 |
Envista Holdings (NVST) | United States | $3.398B | 18.13 |
QuidelOrtho (QDEL) | United States | $3.063B | 19.30 |
Agios Pharmaceuticals (AGIO) | United States | $2.595B | 0.00 |
Green Thumb Industries (GTBIF) | United States | $2.226B | 37.36 |
Maravai LifeSciences Holdings (MRVI) | United States | $2.124B | 0.00 |
LeMaitre Vascular (LMAT) | United States | $2.061B | 54.92 |
Warby Parker (WRBY) | United States | $1.614B | 0.00 |
AdaptHealth (AHCO) | United States | $1.497B | 10.81 |
InMode (INMD) | Israel | $1.464B | 9.32 |
AtriCure (ATRC) | United States | $1.372B | 0.00 |
Owens & Minor (OMI) | United States | $1.247B | 9.63 |
Verano Holdings (VRNOF) | United States | $1.184B | 0.00 |
BioLife Solutions (BLFS) | United States | $1.123B | 0.00 |
Evolus (EOLS) | United States | $1.006B | 0.00 |
PetIQ (PETQ) | United States | $0.919B | 23.30 |
Phibro Animal Health (PAHC) | United States | $0.894B | 18.55 |
Cresco Labs (CRLBF) | United States | $0.805B | 0.00 |
Surmodics (SRDX) | United States | $0.549B | 116.64 |
Quanterix (QTRX) | United States | $0.489B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.488B | 14.72 |
Jin Medical (ZJYL) | China | $0.439B | 0.00 |
ZimVie (ZIMV) | United States | $0.435B | 40.41 |
Valneva SE (VALN) | France | $0.432B | 0.00 |
Canopy Growth (CGC) | Canada | $0.402B | 0.00 |
TerrAscend (TSNDF) | Canada | $0.389B | 0.00 |
Cerus (CERS) | United States | $0.324B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.324B | 0.00 |
OraSure Technologies (OSUR) | United States | $0.320B | 8.25 |
Aurora Cannabis (ACB) | Canada | $0.319B | 0.00 |
Biote (BTMD) | United States | $0.307B | 14.18 |
Viemed Healthcare (VMD) | United States | $0.283B | 30.38 |
Sanara MedTech (SMTI) | United States | $0.264B | 0.00 |
Zynex (ZYXI) | United States | $0.257B | 45.00 |
Utah Medical Products (UTMD) | United States | $0.232B | 15.41 |
Omeros (OMER) | United States | $0.227B | 0.00 |
MacroGenics (MGNX) | United States | $0.200B | 0.00 |
Ayr Wellness (AYRWF) | United States | $0.194B | 0.00 |
Organigram Holdings (OGI) | Canada | $0.191B | 0.00 |
High Tide (HITI) | Canada | $0.163B | 67.33 |
FitLife Brands (FTLF) | United States | $0.153B | 20.64 |
Brainsway (BWAY) | Israel | $0.135B | 161.40 |
TriSalus Life Sciences (TLSI) | United States | $0.130B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.121B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.114B | 0.00 |
Veru (VERU) | United States | $0.113B | 0.00 |
Fonar (FONR) | United States | $0.111B | 11.44 |
Jushi Holdings (JUSHF) | United States | $0.104B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.101B | 24.80 |
InterCure (INCR) | Israel | $0.087B | 14.62 |
Zevia PBC (ZVIA) | United States | $0.083B | 0.00 |
Cytosorbents (CTSO) | United States | $0.082B | 0.00 |
Modular Medical (MODD) | United States | $0.074B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.073B | 0.00 |
Safety Shot (SHOT) | United States | $0.071B | 0.00 |
MariMed (MRMD) | United States | $0.065B | 0.00 |
Exagen (XGN) | United States | $0.055B | 0.00 |
Eagle Pharmaceuticals (EGRX) | United States | $0.051B | 3.35 |
Apyx Medical (APYX) | United States | $0.042B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.040B | 0.00 |
ImmuCell (ICCC) | United States | $0.028B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.026B | 0.00 |
Nephros (NEPH) | United States | $0.018B | 0.00 |
Flora Growth (FLGC) | United States | $0.018B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.014B | 0.00 |
GlucoTrack (GCTK) | United States | $0.013B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.008B | 0.00 |
NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
GUARDION HEALTH (GHSI) | United States | $0.007B | 0.00 |
Agape ATP (ATPC) | $0.007B | 0.00 | |
Leafly Holdings (LFLY) | United States | $0.006B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
Sharps Technology (STSS) | United States | $0.005B | 0.00 |
Senestech (SNES) | United States | $0.001B | 0.00 |
InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.000B | 0.00 |
United-Guardian (UG) | United States | $0.000B | 21.30 |
SNDL (SNDL) | Canada | $0.000B | 0.00 |